Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
Ebiomedicine|March 4, 2021
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infectionCharlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, et al.
Science (New York, N.Y.)|December 2, 2021
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variantsCatherine J Reynolds, Joseph M Gibbons, Corinna Pade, et al.
Frontiers in Immunology|December 6, 2021
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 CasesJavier Castillo-Olivares, David A Wells, Matteo Ferrari, et al.
Immunology|February 14, 2022
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19Stuart Astbury, Catherine J Reynolds, David K Butler, et al.
Cell Reports. Medicine|April 27, 2022
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infectionsAneesh Chandran, Joshua Rosenheim, Gayathri Nageswaran, et al.
The New England Journal of Medicine|February 16, 2022
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionVictoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.
Iscience|June 5, 2023
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infectionMartina Milighetti, Yanchun Peng, Cedric Tan, et al.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
Pageof 4